+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Animal Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Animal Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 210 Pages
  • June 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5913358
Description Jump to:
The global animal stem cell therapy market is on a steady path to transformation, thanks to the growing demand for advanced regenerative treatments in veterinary medicine. As veterinary care evolves to meet the needs of aging pets and performance animals, stem cell therapy is becoming an increasingly favored option. According to a new report, the animal stem cell therapy market is projected to reach US$ 320 Mn in 2025 and further expand to US$ 482 Mn by 2032, reflecting a CAGR of 6.03% during the forecast period.

Market Insights

Stem cell therapy, once considered futuristic, is now a practical solution improving the quality of life for animals suffering from chronic and degenerative conditions. Mesenchymal stem cells (MSCs), in particular, have demonstrated significant efficacy in reducing inflammation and promoting tissue repair in animals with ailments such as osteoarthritis, soft tissue injuries, and tendonitis.

Clinical evidence is emerging in support of stem cell treatments for pets. For instance, over 85% of arthritic dogs undergoing stem cell therapy report improved mobility and reduced discomfort. Similarly, racehorses treated for tendon injuries using stem cells have shown significant recovery, lowering recurrence rates dramatically. These successful outcomes are driving both demand and trust in stem cell applications across veterinary segments.

Market Drivers

The key growth drivers shaping the animal stem cell therapy industry include:

  • Rise in Chronic Pet Conditions: With increasing lifespans of companion animals, chronic diseases such as osteoarthritis, hip dysplasia, and kidney disorders are becoming prevalent. Stem cell therapy offers a less invasive and more effective alternative to traditional treatments.
  • Technological Advancements: Innovations in precision medicine, gene editing, and immune modulation techniques are enhancing the capabilities of stem cell therapies for veterinary applications.
  • Shift Toward Science-Backed Treatments: Veterinarians and pet owners alike are leaning toward regenerative and evidence-based therapies, supporting the adoption of stem cells in clinical settings.
  • Pet Insurance Inclusion: The inclusion of stem cell therapy in pet insurance coverage, especially in regions like North America, is boosting adoption by reducing cost barriers for pet owners.

Business Opportunity

The market is ripe with opportunities for companies and research institutions to collaborate on developing novel stem cell treatments. Collaborative efforts, such as those between Vet-Stem and veterinary schools, are pushing the envelope in clinical trials and therapeutic development. Access to trial participants, shared research, and best practice insights are enabling companies to create more effective therapies.

The market also shows significant promise for businesses offering allogeneic therapy options. These ready-to-use treatments save time and reduce costs associated with invasive procedures required in autologous therapies, thereby making regenerative solutions more accessible to a wider range of veterinary practices.

Region Analysis

North America remains at the forefront of the animal stem cell therapy market, accounting for a notable share due to robust pet insurance infrastructure and high awareness among pet owners. The presence of prominent veterinary research centers, like those at Cornell University, is also contributing to market expansion through ongoing trials and academic research.

Europe is witnessing growth driven by increased focus on canine osteoarthritis treatments. Companies such as Dômes Pharma have introduced licensed stem cell treatments for dogs in France, establishing a stronghold in this niche.

In Latin America, rising investments in regenerative medicine and support from public-sector R&D programs in countries like Uruguay, Mexico, and Chile are fostering innovation. The availability of grants and research centers focusing on animal health is further contributing to regional development.

Key Players

Several notable players are shaping the competitive Analysis of the animal stem cell therapy industry. These include:

  • Aratana Therapeutics, Inc.
  • VetStem, Inc.
  • Magellan Stem Cells
  • StemcellX
  • Boehringer Ingelheim
  • Cell Therapy Sciences
  • VETherapy Corporation
  • MediVet Biologics LLC (Ardent Animal Health)
  • Medrego
  • AniCell Biotech
  • Gallant
  • Companion Animal Health
  • Kintaro Cells Power
  • StemBioSys
  • Regen BioPharma, Inc.
  • Celltex Therapeutics Corporation
  • Regenexx
These companies are focusing on R&D, regulatory approvals, and partnerships to bring effective and commercially viable stem cell therapies to veterinary clinics.

Market Segmentation

By Product Type

  • Hemopoietic Stem Cells
  • Mesenchymal Stem Cells

By Source

  • Allogeneic Animal Stem Cell Therapy
  • Autologous Animal Stem Cell Therapy

By Application

  • Osteoarthritis
  • Soft Tissue Injuries
  • Traumatic Fractures
  • Tendonitis
  • Inflammatory Bowel Disease
  • Others

By Species

  • Canine
  • Feline
  • Equine

By End User

  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Research Institutes

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Animal Stem Cell Therapy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Animal Stem Cell Therapy Market Outlook, 2019-2032
3.1. Global Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2019-2032
3.1.1. Key Highlights
3.1.1.1. Hemopoietic Stem Cells
3.1.1.2. Mesenchymal Stem Cells
3.2. Global Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2019-2032
3.2.1. Key Highlights
3.2.1.1. Allogeneic Animal Stem Cell Therapy
3.2.1.2. Autologous Animal Stem Cell Therapy
3.3. Global Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2019-2032
3.3.1. Key Highlights
3.3.1.1. Osteoarthritis
3.3.1.2. Soft Tissue Injuries
3.3.1.3. Traumatic Fractures
3.3.1.4. Tendonitis
3.3.1.5. Inflammatory Bowel Disease
3.3.1.6. Others
3.4. Global Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2019-2032
3.4.1. Key Highlights
3.4.1.1. Canine
3.4.1.2. Feline
3.4.1.3. Equine
3.5. Global Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2019-2032
3.5.1. Key Highlights
3.5.1.1. Veterinary Hospitals
3.5.1.2. Veterinary Clinics
3.5.1.3. Veterinary Research Institutes
3.6. Global Animal Stem Cell Therapy Market Outlook, by Region, Value (US$ Mn) and Volume, 2019-2032
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa
4. North America Animal Stem Cell Therapy Market Outlook, 2019-2032
4.1. North America Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2019-2032
4.1.1. Key Highlights
4.1.1.1. Hemopoietic Stem Cells
4.1.1.2. Mesenchymal Stem Cells
4.2. North America Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2019-2032
4.2.1. Key Highlights
4.2.1.1. Allogeneic Animal Stem Cell Therapy
4.2.1.2. Autologous Animal Stem Cell Therapy
4.3. North America Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2019-2032
4.3.1. Key Highlights
4.3.1.1. Osteoarthritis
4.3.1.2. Soft Tissue Injuries
4.3.1.3. Traumatic Fractures
4.3.1.4. Tendonitis
4.3.1.5. Inflammatory Bowel Disease
4.3.1.6. Others
4.4. North America Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2019-2032
4.4.1. Key Highlights
4.4.1.1. Canine
4.4.1.2. Feline
4.4.1.3. Equine
4.5. North America Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2019-2032
4.5.1. Key Highlights
4.5.1.1. Veterinary Hospitals
4.5.1.2. Veterinary Clinics
4.5.1.3. Veterinary Research Institutes
4.5.2. BPS Analysis/Market Attractiveness Analysis
4.6. North America Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2019-2032
4.6.1. Key Highlights
4.6.1.1. U.S. Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
4.6.1.2. U.S. Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
4.6.1.3. U.S. Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
4.6.1.4. U.S. Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
4.6.1.5. U.S. Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
4.6.1.6. Canada Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
4.6.1.7. Canada Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
4.6.1.8. Canada Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
4.6.1.9. Canada Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
4.6.1.10. Canada Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
4.6.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Animal Stem Cell Therapy Market Outlook, 2019-2032
5.1. Europe Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.1.1. Key Highlights
5.1.1.1. Hemopoietic Stem Cells
5.1.1.2. Mesenchymal Stem Cells
5.2. Europe Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2019-2032
5.2.1. Key Highlights
5.2.1.1. Allogeneic Animal Stem Cell Therapy
5.2.1.2. Autologous Animal Stem Cell Therapy
5.3. Europe Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2019-2032
5.3.1. Key Highlights
5.3.1.1. Osteoarthritis
5.3.1.2. Soft Tissue Injuries
5.3.1.3. Traumatic Fractures
5.3.1.4. Tendonitis
5.3.1.5. Inflammatory Bowel Disease
5.3.1.6. Others
5.4. Europe Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2019-2032
5.4.1. Key Highlights
5.4.1.1. Canine
5.4.1.2. Feline
5.4.1.3. Equine
5.5. Europe Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2019-2032
5.5.1. Key Highlights
5.5.1.1. Veterinary Hospitals
5.5.1.2. Veterinary Clinics
5.5.1.3. Veterinary Research Institutes
5.5.2. BPS Analysis/Market Attractiveness Analysis
5.6. Europe Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2019-2032
5.6.1. Key Highlights
5.6.1.1. Germany Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.6.1.2. Germany Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
5.6.1.3. Germany Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
5.6.1.4. Germany Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
5.6.1.5. Germany Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
5.6.1.6. U.K. Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.6.1.7. U.K. Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
5.6.1.8. U.K. Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
5.6.1.9. U.K. Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
5.6.1.10. U.K. Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
5.6.1.11. France Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.6.1.12. France Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
5.6.1.13. France Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
5.6.1.14. France Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
5.6.1.15. France Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
5.6.1.16. Italy Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.6.1.17. Italy Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
5.6.1.18. Italy Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
5.6.1.19. Italy Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
5.6.1.20. Italy Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
5.6.1.21. Turkey Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.6.1.22. Turkey Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
5.6.1.23. Turkey Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
5.6.1.24. Turkey Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
5.6.1.25. Turkey Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
5.6.1.26. Russia Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.6.1.27. Russia Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
5.6.1.28. Russia Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
5.6.1.29. Russia Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
5.6.1.30. Russia Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
5.6.1.31. Rest of Europe Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
5.6.1.32. Rest of Europe Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
5.6.1.33. Rest of Europe Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
5.6.1.34. Rest of Europe Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
5.6.1.35. Rest of Europe Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
5.6.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Animal Stem Cell Therapy Market Outlook, 2019-2032
6.1. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2019-2032
6.1.1. Key Highlights
6.1.1.1. Hemopoietic Stem Cells
6.1.1.2. Mesenchymal Stem Cells
6.2. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2019-2032
6.2.1. Key Highlights
6.2.1.1. Allogeneic Animal Stem Cell Therapy
6.2.1.2. Autologous Animal Stem Cell Therapy
6.3. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2019-2032
6.3.1. Key Highlights
6.3.1.1. Osteoarthritis
6.3.1.2. Soft Tissue Injuries
6.3.1.3. Traumatic Fractures
6.3.1.4. Tendonitis
6.3.1.5. Inflammatory Bowel Disease
6.3.1.6. Others
6.4. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2019-2032
6.4.1. Key Highlights
6.4.1.1. Canine
6.4.1.2. Feline
6.4.1.3. Equine
6.5. Asia Pacific Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2019-2032
6.5.1. Key Highlights
6.5.1.1. Veterinary Hospitals
6.5.1.2. Veterinary Clinics
6.5.1.3. Veterinary Research Institutes
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. Asia Pacific Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2019-2032
6.6.1. Key Highlights
6.6.1.1. China Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
6.6.1.2. China Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
6.6.1.3. China Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
6.6.1.4. China Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
6.6.1.5. China Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
6.6.1.6. Japan Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
6.6.1.7. Japan Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
6.6.1.8. Japan Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
6.6.1.9. Japan Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
6.6.1.10. Japan Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
6.6.1.11. South Korea Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
6.6.1.12. South Korea Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
6.6.1.13. South Korea Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
6.6.1.14. South Korea Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
6.6.1.15. South Korea Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
6.6.1.16. India Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
6.6.1.17. India Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
6.6.1.18. India Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
6.6.1.19. India Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
6.6.1.20. India Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
6.6.1.21. Southeast Asia Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
6.6.1.22. Southeast Asia Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
6.6.1.23. Southeast Asia Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
6.6.1.24. Southeast Asia Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
6.6.1.25. Southeast Asia Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
6.6.1.26. Rest of Asia Pacific Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
6.6.1.27. Rest of Asia Pacific Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
6.6.1.28. Rest of Asia Pacific Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
6.6.1.29. Rest of Asia Pacific Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
6.6.1.30. Rest of Asia Pacific Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
6.6.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Animal Stem Cell Therapy Market Outlook, 2019-2032
7.1. Latin America Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2019-2032
7.1.1. Key Highlights
7.1.1.1. Hemopoietic Stem Cells
7.1.1.2. Mesenchymal Stem Cells
7.2. Latin America Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2019-2032
7.2.1.1. Allogeneic Animal Stem Cell Therapy
7.2.1.2. Autologous Animal Stem Cell Therapy
7.3. Latin America Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2019-2032
7.3.1. Key Highlights
7.3.1.1. Osteoarthritis
7.3.1.2. Soft Tissue Injuries
7.3.1.3. Traumatic Fractures
7.3.1.4. Tendonitis
7.3.1.5. Inflammatory Bowel Disease
7.3.1.6. Others
7.4. Latin America Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2019-2032
7.4.1. Key Highlights
7.4.1.1. Canine
7.4.1.2. Feline
7.4.1.3. Equine
7.5. Latin America Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2019-2032
7.5.1. Key Highlights
7.5.1.1. Veterinary Hospitals
7.5.1.2. Veterinary Clinics
7.5.1.3. Veterinary Research Institutes
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2019-2032
7.6.1. Key Highlights
7.6.1.1. Brazil Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
7.6.1.2. Brazil Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
7.6.1.3. Brazil Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
7.6.1.4. Brazil Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
7.6.1.5. Brazil Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
7.6.1.6. Mexico Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
7.6.1.7. Mexico Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
7.6.1.8. Mexico Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
7.6.1.9. Mexico Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
7.6.1.10. Mexico Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
7.6.1.11. Argentina Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
7.6.1.12. Argentina Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
7.6.1.13. Argentina Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
7.6.1.14. Argentina Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
7.6.1.15. Argentina Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
7.6.1.16. Rest of Latin America Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
7.6.1.17. Rest of Latin America Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
7.6.1.18. Rest of Latin America Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
7.6.1.19. Rest of Latin America Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
7.6.1.20. Rest of Latin America Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
7.6.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Animal Stem Cell Therapy Market Outlook, 2019-2032
8.1. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Product Type, Value (US$ Mn) and Volume, 2019-2032
8.1.1. Key Highlights
8.1.1.1. Hemopoietic Stem Cells
8.1.1.2. Mesenchymal Stem Cells
8.2. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Source, Value (US$ Mn) and Volume, 2019-2032
8.2.1. Key Highlights
8.2.1.1. Allogeneic Animal Stem Cell Therapy
8.2.1.2. Autologous Animal Stem Cell Therapy
8.3. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Application, Value (US$ Mn) and Volume, 2019-2032
8.3.1. Key Highlights
8.3.1.1. Osteoarthritis
8.3.1.2. Soft Tissue Injuries
8.3.1.3. Traumatic Fractures
8.3.1.4. Tendonitis
8.3.1.5. Inflammatory Bowel Disease
8.3.1.6. Others
8.4. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Species, Value (US$ Mn) and Volume, 2019-2032
8.4.1. Key Highlights
8.4.1.1. Canine
8.4.1.2. Feline
8.4.1.3. Equine
8.5. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by End Use, Value (US$ Mn) and Volume, 2019-2032
8.5.1. Key Highlights
8.5.1.1. Veterinary Hospitals
8.5.1.2. Veterinary Clinics
8.5.1.3. Veterinary Research Institutes
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Middle East & Africa Animal Stem Cell Therapy Market Outlook, by Country, Value (US$ Mn) and Volume, 2019-2032
8.6.1. Key Highlights
8.6.1.1. GCC Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
8.6.1.2. GCC Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
8.6.1.3. GCC Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
8.6.1.4. GCC Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
8.6.1.5. GCC Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
8.6.1.6. South Africa Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
8.6.1.7. South Africa Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
8.6.1.8. South Africa Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
8.6.1.9. South Africa Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
8.6.1.10. South Africa Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
8.6.1.11. Egypt Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
8.6.1.12. Egypt Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
8.6.1.13. Egypt Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
8.6.1.14. Egypt Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
8.6.1.15. Egypt Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
8.6.1.16. Nigeria Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
8.6.1.17. Nigeria Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
8.6.1.18. Nigeria Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
8.6.1.19. Nigeria Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
8.6.1.20. Nigeria Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
8.6.1.21. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Product Type, Value (US$ Mn) and Volume, 2019-2032
8.6.1.22. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Source, Value (US$ Mn) and Volume, 2019-2032
8.6.1.23. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Application, Value (US$ Mn) and Volume, 2019-2032
8.6.1.24. Rest of Middle East & Africa Animal Stem Cell Therapy Market by Species, Value (US$ Mn) and Volume, 2019-2032
8.6.1.25. Rest of Middle East & Africa Animal Stem Cell Therapy Market by End Use, Value (US$ Mn) and Volume, 2019-2032
8.6.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Species vs by Source Heat map
9.2. Manufacturer vs by Source Heat map
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Aratana Therapeutics, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. VetStem, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Regeneus Ltd.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Magellan Stem Cells
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. PrimeGen Biotech, LLC
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Vetbiologics (U.S. Stem Cell, Inc.)
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Boehringer Ingelheim (Global stem cell technology)
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Cell Therapy Sciences
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. MediVet Biologics LLC (Ardent Animal Health)
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Animal Cell Therapies, Inc
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Medrego
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. AniCell Biotech
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. VETherapy Corporation
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Aratana Therapeutics, Inc.
  • VetStem, Inc.
  • Magellan Stem Cells
  • StemcellX
  • Boehringer Ingelheim (Global stem cell technology)
  • Cell Therapy Sciences
  • VETherapy Corporation
  • MediVet Biologics LLC (Ardent Animal Health)
  • Medrego
  • AniCell Biotech
  • Gallant
  • Companion Animal Health
  • Kintaro Cells Power
  • StemBioSys
  • Regen BioPharma, Inc.
  • Celltex Therapeutics Corporation
  • Regenexx

Related Topics

Related Reports

Animal Stem Cell Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Animal Stem Cell Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
Animal Stem Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Animal Stem Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Animal Stem Cell Therapy Market By Product Type, By Type of Stem Cells, By Application, Species, and End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035 - Product Image

Animal Stem Cell Therapy Market By Product Type, By Type of Stem Cells, By Application, Species, and End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

  • Report
  • 215 Pages
  • Global
From
Autologous Stem Cell and Non-Stem Cell Therapies Market Report and Forecast 2025-2034 - Product Image

Autologous Stem Cell and Non-Stem Cell Therapies Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Stem Cell Therapy Market Report 2025 - Product Image

Stem Cell Therapy Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.